Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Br J Ophthalmol. 2008 Oct 1;93(2):198–202. doi: 10.1136/bjo.2008.147298

Table 2.

Baseline Characteristics of Patients (n=42)

Placebo N (%) Steroid N (%) P-value
Age (mean years ± SD) 44.1 ± 17.0 49.9 ± 13.0 0.22*
Sex
Male 11 (50.0) 11 (55.0) 0.75**
Female 11 (50.0) 9 (45.0)
Organisms
Coagulase-neg Staphylococcus 3 (13.64) 2 (9.52)
Diphtheroids - 1 (4.76)
Staphylococcus aureus 2 (9.09) -
Streptococcus pneumoniae 10 (45.45) 9 (42.86)
 Viridans-group Streptococcus spp 1 (4.55) 3 (14.29) 0.51**
Haemophilus influenzae - 1 (4.76)
Moraxella spp 1 (4.55) -
Pseudomonas spp (non-aeruginosa) - 1 (4.76)
Pseudomonas aeruginosa 4 (18.18) 4 (19.05)
Aeromonas hydophila 1 (4.55) -
Mean enrollment visual acuity (logMAR ± SD) 1.15 ± 0.63 1.28 ± 0.54 0.50*
Mean enrollment infiltrate/scar diameter (mm ± SD) 1.8 ± 1.6 2.0 ± 1.2 0.63*
*

Independent sample t-test

**

Fisher’s exact test